Bruker Statistics
Total Valuation
Bruker has a market cap or net worth of $7.70 billion. The enterprise value is $9.62 billion.
Important Dates
The last earnings date was Thursday, February 13, 2025, before market open.
| Earnings Date | Feb 13, 2025 |
| Ex-Dividend Date | Dec 2, 2024 |
Share Statistics
Bruker has 151.60 million shares outstanding. The number of shares has increased by 1.56% in one year.
| Current Share Class | 151.60M |
| Shares Outstanding | 151.60M |
| Shares Change (YoY) | +1.56% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 31.92% |
| Owned by Institutions (%) | 77.95% |
| Float | 103.08M |
Valuation Ratios
The trailing PE ratio is 66.95 and the forward PE ratio is 18.97. Bruker's PEG ratio is 1.63.
| PE Ratio | 66.95 |
| Forward PE | 18.97 |
| PS Ratio | 2.25 |
| Forward PS | 2.14 |
| PB Ratio | 4.29 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 57.58 |
| P/OCF Ratio | 30.67 |
| PEG Ratio | 1.63 |
Financial Ratio HistoryEnterprise Valuation
The stock's EV/EBITDA ratio is 20.44, with an EV/FCF ratio of 71.86.
| EV / Earnings | 85.01 |
| EV / Sales | 2.86 |
| EV / EBITDA | 20.44 |
| EV / EBIT | 33.54 |
| EV / FCF | 71.86 |
Financial Position
The company has a current ratio of 1.60, with a Debt / Equity ratio of 1.15.
| Current Ratio | 1.60 |
| Quick Ratio | 0.58 |
| Debt / Equity | 1.15 |
| Debt / EBITDA | 4.45 |
| Debt / FCF | 15.65 |
| Interest Coverage | 20.63 |
Financial Efficiency
Return on equity (ROE) is 7.05% and return on invested capital (ROIC) is 5.33%.
| Return on Equity (ROE) | 7.05% |
| Return on Assets (ROA) | 3.56% |
| Return on Invested Capital (ROIC) | 5.33% |
| Return on Capital Employed (ROCE) | 6.33% |
| Revenue Per Employee | $346,801 |
| Profits Per Employee | $11,651 |
| Employee Count | 9,707 |
| Asset Turnover | 0.67 |
| Inventory Turnover | 1.65 |
Taxes
In the past 12 months, Bruker has paid $91.40 million in taxes.
| Income Tax | 91.40M |
| Effective Tax Rate | 44.54% |
Stock Price Statistics
The stock price has decreased by -37.34% in the last 52 weeks. The beta is 1.16, so Bruker's price volatility has been higher than the market average.
| Beta (5Y) | 1.16 |
| 52-Week Price Change | -37.34% |
| 50-Day Moving Average | 56.98 |
| 200-Day Moving Average | 62.43 |
| Relative Strength Index (RSI) | 38.94 |
| Average Volume (20 Days) | 1,743,265 |
Short Selling Information
The latest short interest is 6.75 million, so 4.45% of the outstanding shares have been sold short.
| Short Interest | 6.75M |
| Short Previous Month | 6.24M |
| Short % of Shares Out | 4.45% |
| Short % of Float | 6.55% |
| Short Ratio (days to cover) | 4.60 |
Income Statement
In the last 12 months, Bruker had revenue of $3.37 billion and earned $113.10 million in profits. Earnings per share was $0.76.
| Revenue | 3.37B |
| Gross Profit | 1.68B |
| Operating Income | 286.70M |
| Pretax Income | 455.90M |
| Net Income | 113.10M |
| EBITDA | 470.50M |
| EBIT | 286.70M |
| Earnings Per Share (EPS) | $0.76 |
Full Income StatementBalance Sheet
The company has $183.40 million in cash and $2.09 billion in debt, giving a net cash position of -$1.91 billion or -$12.61 per share.
| Cash & Cash Equivalents | 183.40M |
| Total Debt | 2.09B |
| Net Cash | -1.91B |
| Net Cash Per Share | -$12.61 |
| Equity (Book Value) | 1.82B |
| Book Value Per Share | 11.85 |
| Working Capital | 773.70M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $251.20 million and capital expenditures -$117.40 million, giving a free cash flow of $133.80 million.
| Operating Cash Flow | 251.20M |
| Capital Expenditures | -117.40M |
| Free Cash Flow | 133.80M |
| FCF Per Share | $0.88 |
Full Cash Flow StatementMargins
Gross margin is 50.00%, with operating and profit margins of 8.52% and 3.36%.
| Gross Margin | 50.00% |
| Operating Margin | 8.52% |
| Pretax Margin | 6.10% |
| Profit Margin | 3.36% |
| EBITDA Margin | 13.98% |
| EBIT Margin | 8.52% |
| FCF Margin | 3.97% |